Hypothalamic Obesity in man and animals is associated with an increase in body fat. The objective of this research proposal is to explore the mechanisms which underlie the development of this type of clinical obesity, using animal models for this purpose. Three major mechanisms have been proposed to explain the development and maintenance of hypothalamic obesity. They are: hyperphagia, hyperinsulinemia, and reduced activity of the sympathetic nervous system. We will explore the role of these mechanisms by using three types of hypothalamic obesity in which these elements can be separated or co-mingled. In weanling rats, a ventromedial hypothalamic lesion increases insulin, reduce sympathetic activity, but does not produce hyperphagia. In rats with PVN-lesions, there is hyperphagia with little evidence for disturbed function of the autonomic nervous system. In adult rats with VMH-lesions, the hyperphagia, hyperinsulinemia and reduced activity of the sympathetic nervous system co-exist. The hypothesis that hyperphagia is an adequate explanation for either of the adult syndromes can be critically addressed by appropriate forms of paired feeding. The possibility that reduced activity alone could induce obesity will be examined in the diabetic weanling rat in which insulin is infused at a constant rate. The role of insulin as a driver of food intake will be tested by infusing insulin either subcutaneously or into the peritoneal space in diabetic adult rats with hypothalamic lesions. The role of insulin as a signal for regulating the plateau which develops during the new steady state after hypothalamic lesions will be studied by raising or lowering insulin in lesioned animals which have reached a plateau weight. Finally, the relationship of the activity of the sympathetic and parasympathetic nervous systems to the plateau state will be assessed by measuring the firing rate of sympathetic nerves to brown adipose tissue and by stimulating the vagal response with injections of insulin into the hypothalamus.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK031988-07
Application #
3230462
Study Section
Metabolism Study Section (MET)
Project Start
1982-04-01
Project End
1989-11-30
Budget Start
1988-12-01
Budget End
1989-11-30
Support Year
7
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Smith, B K; Andrews, P K; York, D A et al. (1999) Divergence in proportional fat intake in AKR/J and SWR/J mice endures across diet paradigms. Am J Physiol 277:R776-85
Koegler, F H; York, D A; Bray, G A (1999) The effects on feeding of galanin and M40 when injected into the nucleus of the solitary tract, the lateral parabrachial nucleus, and the third ventricle. Physiol Behav 67:259-67
Smith, B K; York, D A; Bray, G A (1998) Chronic d-fenfluramine treatment reduces fat intake independent of macronutrient preference. Pharmacol Biochem Behav 60:105-14
Tsujii, S; Bray, G A (1998) A beta-3 adrenergic agonist (BRL-37,344) decreases food intake. Physiol Behav 63:723-8
Smith, B K; West, D B; York, D A (1997) Carbohydrate versus fat intake: differing patterns of macronutrient selection in two inbred mouse strains. Am J Physiol 272:R357-62
Bray, G A (1993) The nutrient balance hypothesis: peptides, sympathetic activity, and food intake. Ann N Y Acad Sci 676:223-41
Egawa, M; Yoshimatsu, H; Bray, G A (1993) Effect of beta-endorphin on sympathetic nerve activity to interscapular brown adipose tissue. Am J Physiol 264:R109-15
Yoshimatsu, H; Egawa, M; Bray, G A (1993) Sympathetic nerve activity after discrete hypothalamic injections of L-glutamate. Brain Res 601:121-8
Bray, G A (1992) Genetic, hypothalamic and endocrine features of clinical and experimental obesity. Prog Brain Res 93:333-40;discussion 340-1
Yoshimatsu, H; Egawa, M; Bray, G A (1992) Effects of cholecystokinin on sympathetic activity to interscapular brown adipose tissue. Brain Res 597:298-303

Showing the most recent 10 out of 28 publications